Could faecal transplants cause long-term health problems?
Keeping a healthy mix of friendly microbes in the gut – known as eubiosis – is crucial for good health. When that delicate balance is thrown off – often by antibiotics, diet or illness – the result can be a range of issues, from digestive problems to more serious conditions like Crohn's disease, ulcerative colitis, and even neurological and metabolic disorders.
One increasingly popular way to try to restore gut health is through faecal microbiota transplantation. This involves taking stool from a healthy person, isolating the beneficial microbes and putting them in a capsule (jokingly referred to as 'crapsules' or 'poo pills'). The hope is that the beneficial microbes in the pill will establish themselves in the patient's gut, thereby improving microbial diversity and function.
Faecal transplants have been used to treat a wide array of conditions, including irritable bowel syndrome, Parkinson's disease, obesity and Type 2 diabetes.
Although generally viewed as safe and effective, a new international study published in the journal Cell has raised some concerns. The scientists found that when the donor's microbes do not properly match the recipient's gut environment – a situation they describe as a 'mismatch' – the treatment can disrupt the body's metabolic and immune systems, possibly with long-lasting consequences.
Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences.
The term 'mismatch' comes from the world of organ transplants, where the recipient's body rejects the donor organ. In this case, the problem is that microbes from the donor's large intestine may not be suitable for other parts of the recipient's gut, especially the small intestine, where the microbial makeup is very different.
To test this, researchers gave antibiotics to mice to disturb their natural gut microbes, then treated them with faecal transplants. They also tried transplanting microbes specifically from different parts of the small intestine. The mice were monitored for one to three months to track changes.
They found that faecal transplants often led to regional mismatches – the wrong microbes ending up in the wrong place. This altered the mix and behaviour of the gut microbes in unexpected ways, disrupting energy balance and other functions.
Biopsies from the gut and liver showed significant, lasting changes in how certain genes – particularly those linked to metabolism and immunity – were being expressed.
The study did not specify exactly what kind of health issues might result from these genetic shifts. But the researchers are urging doctors to take greater care when using faecal transplants, particularly when it comes to dose, timing and possible side-effects.
There may, however, be a better way forward. A newer method known as the 'omni microbial approach' involves transferring microbes from all parts of the intestine, not just the colon. This could help recreate a more balanced and natural gut environment, avoiding the local mismatches seen in standard faecal transplants.
There is also growing interest in techniques that aim to 'terraform' the gut: deliberately reshaping specific regions with carefully selected microbes to restore normal function.
This new research has certainly sparked debate around the safety of faecal transplants. But with alternative approaches already being developed, there is real hope that the benefits of gut-based treatments can still be delivered, without the risks.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Georgios Efthimiou does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
10 hours ago
- Newsweek
This New Test Could Diagnose Parkinson's With AI
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new artificial intelligence (AI) tool analyzing short smile videos achieved high accuracy in screening for Parkinson's disease (PD), according to research published by Tariq Adnan, and colleagues in the New England Journal of Medicine (NEJM) Thursday. The model was trained on the largest known video dataset of facial expressions to date, enrolling 1,452 participants, including 391 living with PD. An 87.9 percent overall accuracy in detecting PD using only smile video analysis, the NEJM AI study reported. Researchers reported that the AI model could accurately distinguish between individuals with and without PD based on the analysis of their smiles, even when applied in diverse population samples from North America and Bangladesh. Why It Matters The Parkinson's Foundation says an estimated 90,000 more people will be diagnosed this year, with the number of those suffering expected to be around 1.2 million by 2030. Diagnosing Parkinson's disease early remains a significant challenge because of limited access to clinical expertise and in-person evaluations. AI-driven remote screening tools promise scalable, cost-effective solutions to bridge these healthcare gaps. The findings align with the growing demand for digital healthcare solutions that remove geographical and economic barriers to early neurological disease diagnosis, which is especially relevant to rural and underserved American communities. What To Know The new screening method invited participants to record themselves mimicking facial expressions—including a smile—using an online platform. Research teams then extracted facial landmarks and measured action units to quantify hypomimia, a common motor symptom in PD where facial muscle movement is diminished. Machine learning models were developed using these features, distinguishing people with PD from those without. The approach relied on a broad recruitment strategy, involving participants from North America via social media, email, wellness centers, and research registries, alongside a high-risk cohort from Bangladesh. Trained solely on smile videos, the model achieved a 10-fold cross-validated accuracy of 87.9 percent, a sensitivity of 76.8 percent, and a specificity of 91.4 percent. Validation in external test sets revealed 80.3 percent accuracy in a U.S. clinic dataset and 85.3 percent accuracy in the Bangladesh cohort. While the negative predictive value remained above 92 percent in all settings, the positive predictive value dropped to 35.7 percent among the Bangladeshi participants, reflecting variations in population characteristics. The study found no significant differences in model performance across sex and ethnic subgroups, except for marginally higher accuracy in female participants in Bangladesh. The authors emphasized the generalizability and fairness of the approach, key considerations in the development of clinical AI tools. The video-processing and machine-learning code supporting the study is available to the public on GitHub. However, the study authors noted that raw video data sharing is restricted to comply with U.S. healthcare privacy law (HIPAA), limiting access to de-identified derivative features only. The research received funding from the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, among other sources. The work was a collaborative effort involving academic and clinical partners such as the InMotion Parkinson's Disease wellness center and the University of Rochester Center for Health and Technology. The research process also benefited from contributions by staff at Google Research and the University of Rochester, particularly in statistical analysis. Stock image of brain MRI taken November 21, 2018. Stock image of brain MRI taken November 21, 2018. Getty What People Are Saying Tariq Adnan, lead author said in the study conclusion: "Smiling videos can effectively differentiate between individuals with and without PD, offering a potentially easy, accessible, and cost-efficient way to screen for PD, especially when access to clinical diagnosis is limited." What Happens Next? Future steps for the research team involve wider validation of the AI screening method in additional, real-world populations and further refinement of the algorithm to maximize early detection accuracy. Regulatory and clinical translation pathways will determine if and when this technology becomes available in the United States healthcare system.
Yahoo
a day ago
- Yahoo
Solar-Powered Slug Steals Chloroplasts and Stores Them for Emergency Food
'Solar-powered' sea slugs have specialized depots in their cells that store photosynthetic equipment looted from algae, a study reports. These depots provide just the right chemical environment to keep the stolen apparatus, called chloroplasts, alive and working to turn sunlight into nutrients. 'It was the wildest thing that we had seen,' says study co-author Nicholas Bellono, a biologist at Harvard University in Cambridge, Massachusetts. The authors also found that, in lean times, the slugs can raid these compartments to consume chloroplasts. The compartment 'is basically like a moving refrigerator of chloroplasts where, after a period of starvation, the slugs can switch from storage to consumption to survive', Bellono says. [Sign up for Today in Science, a free daily newsletter] The findings were published in Cell. Scientists discovered decades ago that certain species of sea slug store chloroplasts from the algae they eat, a diet that can turn the slugs bright green. But no one understood how the slugs keep these foreign organelles alive without the support of the rest of the algal cell. Bellono and his team added chemical tags to proteins newly made by the slugs' own cells. They found that most of the proteins in a slug's chloroplasts were made by the slug — not by the original algae. That meant the slug was helping to maintain the chloroplasts. When the scientists looked at the chloroplasts under a microscope, they found that the organelles were housed in special compartments in the slugs' guts. Each compartment was surrounded by a membrane that tested positive for markers typically found in cellular structures called phagosomes, which fuse with other structures called lysomes to digest unneeded organelles. The researchers named this structure the kleptosome, after a Greek word that means to steal. The team also found that these organelles contained ion channels — receptors that convert chemical messages into electrical signals. Among them is one called P2X4, which opens in response to the presence of ATP, an energy-carrying molecule produced during photosynthesis. When Bellono and his team blocked this channel in slugs' kleptosomes, oxygen production from photosynthesis dropped, showing that the kleptosome is actively involved in keeping the chloroplasts functioning. Having discovered the existence of the kleptosome, the researchers wondered whether it helps the slugs to resist starvation. They compared the solar-powered slug Elysia crispata with Aplysia californica, a non-photosynthetic slug that lacks kleptosomes. Aplysia died after three to four weeks without food, whereas Elysia could survive for up to four months. Yet, after four weeks, the Elysia slugs lost their green colour, turned orange — just as leaves do in autumn — and stopped photosynthesizing. Microscopy revealed that the Elysia's kleptosomes had begun fusing with lysosomes and that the colour change was caused by the degradation of the chloroplast. The study is 'remarkable,' says cell biologist Elena Oancea at Brown University in Providence, Rhode Island. Studying the molecular and cellular processes of creatures as small as sea slugs is extremely challenging, she says. 'It takes a lot of courage to do that.' The discovery of the kleptosome could help to answer broader questions about organelle evolution and other cellular processes that we don't understand yet, Oancea says. All life is built on cells, she adds: 'It's the basic principle of nature.' This article is reproduced with permission and was first published on June 25, 2025.
Scientific American
2 days ago
- Scientific American
This Solar-Powered Slug Steals Photosynthetic Machinery for Emergency Food
' Solar-powered' sea slugs have specialized depots in their cells that store photosynthetic equipment looted from algae, a study reports. These depots provide just the right chemical environment to keep the stolen apparatus, called chloroplasts, alive and working to turn sunlight into nutrients. 'It was the wildest thing that we had seen,' says study co-author Nicholas Bellono, a biologist at Harvard University in Cambridge, Massachusetts. The authors also found that, in lean times, the slugs can raid these compartments to consume chloroplasts. The compartment 'is basically like a moving refrigerator of chloroplasts where, after a period of starvation, the slugs can switch from storage to consumption to survive', Bellono says. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. The findings were published in Cell. Green grazer Scientists discovered decades ago that certain species of sea slug store chloroplasts from the algae they eat, a diet that can turn the slugs bright green. But no one understood how the slugs keep these foreign organelles alive without the support of the rest of the algal cell. Bellono and his team added chemical tags to proteins newly made by the slugs' own cells. They found that most of the proteins in a slug's chloroplasts were made by the slug — not by the original algae. That meant the slug was helping to maintain the chloroplasts. When the scientists looked at the chloroplasts under a microscope, they found that the organelles were housed in special compartments in the slugs' guts. Each compartment was surrounded by a membrane that tested positive for markers typically found in cellular structures called phagosomes, which fuse with other structures called lysomes to digest unneeded organelles. The researchers named this structure the kleptosome, after a Greek word that means to steal. Life of crime The team also found that these organelles contained ion channels — receptors that convert chemical messages into electrical signals. Among them is one called P2X4, which opens in response to the presence of ATP, an energy-carrying molecule produced during photosynthesis. When Bellono and his team blocked this channel in slugs' kleptosomes, oxygen production from photosynthesis dropped, showing that the kleptosome is actively involved in keeping the chloroplasts functioning. Having discovered the existence of the kleptosome, the researchers wondered whether it helps the slugs to resist starvation. They compared the solar-powered slug Elysia crispata with Aplysia californica, a non-photosynthetic slug that lacks kleptosomes. Aplysia died after three to four weeks without food, whereas Elysia could survive for up to four months. Yet, after four weeks, the Elysia slugs lost their green colour, turned orange — just as leaves do in autumn — and stopped photosynthesizing. Microscopy revealed that the Elysia 's kleptosomes had begun fusing with lysosomes and that the colour change was caused by the degradation of the chloroplast. The study is 'remarkable,' says cell biologist Elena Oancea at Brown University in Providence, Rhode Island. Studying the molecular and cellular processes of creatures as small as sea slugs is extremely challenging, she says. 'It takes a lot of courage to do that.' The discovery of the kleptosome could help to answer broader questions about organelle evolution and other cellular processes that we don't understand yet, Oancea says. All life is built on cells, she adds: 'It's the basic principle of nature.'
